Literature DB >> 24975935

Structural enzymology and inhibition of the bi-functional folate pathway enzyme HPPK-DHPS from the biowarfare agent Francisella tularensis.

Gary X Shaw1, Yue Li, Genbin Shi, Yan Wu, Scott Cherry, Danielle Needle, Di Zhang, Joseph E Tropea, David S Waugh, Honggao Yan, Xinhua Ji.   

Abstract

UNLABELLED: Two valid targets for antibiotic development, 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK) and dihydropteroate synthase (DHPS), catalyze consecutive reactions in folate biosynthesis. In Francisella tularensis (Ft), these two activities are contained in a single protein, FtHPPK-DHPS. Although Pemble et al. (PLoS One 5, e14165) determined the structure of FtHPPK-DHPS, they were unable to measure the kinetic parameters of the enzyme. In this study, we elucidated the binding and inhibitory activities of two HPPK inhibitors (HP-18 and HP-26) against FtHPPK-DHPS, determined the structure of FtHPPK-DHPS in complex with HP-26, and measured the kinetic parameters for the dual enzymatic activities of FtHPPK-DHPS. The biochemical analyses showed that HP-18 and HP-26 have significant isozyme selectivity, and that FtHPPK-DHPS is unique in that the catalytic efficiency of its DHPS activity is only 1/260,000 of that of Escherichia coli DHPS. Sequence and structural analyses suggest that HP-26 is an excellent lead for developing therapeutic agents for tularemia, and that the very low DHPS activity is due, at least in part, to the lack of a key residue that interacts with the substrate p-aminobenzoic acid (pABA). A BLAST search of the genomes of ten F. tularensis strains indicated that the bacterium contains a single FtHPPK-DHPS. The marginal DHPS activity and the single copy existence of FtHPPK-DHPS in F. tularensis make this bacterium more vulnerable to DHPS inhibitors. Current sulfa drugs are ineffective against tularemia; new inhibitors targeting the unique pABA-binding pocket may be effective and less subject to resistance because any mutations introducing resistance may make the marginal DHPS activity unable to support the growth of F. tularensis. DATABASE: The coordinates and structure factors have been deposited in the Protein Data Bank under accession code 4PZV. Published 2014. This article has been contributed to by US Government employees and their work is in the public domain in the USA.

Entities:  

Keywords:  DHPS; Francisella tularensis; HPPK; antibiotic; folate

Mesh:

Substances:

Year:  2014        PMID: 24975935      PMCID: PMC5600157          DOI: 10.1111/febs.12896

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  46 in total

1.  EVALUATION OF LIVE TULAREMIA VACCINE PREPARED IN A CHEMICALLY DEFINED MEDIUM.

Authors:  R E CHAMBERLAIN
Journal:  Appl Microbiol       Date:  1965-03

Review 2.  Where will new antibiotics come from?

Authors:  Christopher Walsh
Journal:  Nat Rev Microbiol       Date:  2003-10       Impact factor: 60.633

3.  WHAT IF: a molecular modeling and drug design program.

Authors:  G Vriend
Journal:  J Mol Graph       Date:  1990-03

4.  Gateway vectors for the production of combinatorially-tagged His6-MBP fusion proteins in the cytoplasm and periplasm of Escherichia coli.

Authors:  Sreedevi Nallamsetty; Brian P Austin; Kerri J Penrose; David S Waugh
Journal:  Protein Sci       Date:  2005-12       Impact factor: 6.725

5.  Characterization of a mutationally altered dihydropteroate synthase contributing to sulfathiazole resistance in Escherichia coli.

Authors:  G Vedantam; B P Nichols
Journal:  Microb Drug Resist       Date:  1998       Impact factor: 3.431

6.  Catalysis and sulfa drug resistance in dihydropteroate synthase.

Authors:  Mi-Kyung Yun; Yinan Wu; Zhenmei Li; Ying Zhao; M Brett Waddell; Antonio M Ferreira; Richard E Lee; Donald Bashford; Stephen W White
Journal:  Science       Date:  2012-03-02       Impact factor: 47.728

Review 7.  Role of protein conformational dynamics in the catalysis by 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase.

Authors:  Honggao Yan; Xinhua Ji
Journal:  Protein Pept Lett       Date:  2011-04       Impact factor: 1.890

8.  Purification and partial characterization of 7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase and 7,8-dihydropteroate synthase from Escherichia coli MC4100.

Authors:  T L Talarico; I K Dev; W S Dallas; R Ferone; P H Ray
Journal:  J Bacteriol       Date:  1991-11       Impact factor: 3.490

9.  Crystal structure of 7,8-dihydropteroate synthase from Bacillus anthracis: mechanism and novel inhibitor design.

Authors:  Kerim Babaoglu; Jianjun Qi; Richard E Lee; Stephen W White
Journal:  Structure       Date:  2004-09       Impact factor: 5.006

10.  Chemical transformation is not rate-limiting in the reaction catalyzed by Escherichia coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase.

Authors:  Yue Li; Yunchen Gong; Genbin Shi; Jaroslaw Blaszczyk; Xinhua Ji; Honggao Yan
Journal:  Biochemistry       Date:  2002-07-09       Impact factor: 3.162

View more
  4 in total

1.  Introduction: celebrating the international year of crystallography: introduction.

Authors:  Mariusz Jaskolski; Alexander Wlodawer
Journal:  FEBS J       Date:  2014-09       Impact factor: 5.542

2.  Crystal structure of Arabidopsis thaliana HPPK/DHPS, a bifunctional enzyme and target of the herbicide asulam.

Authors:  Grishma Vadlamani; Kirill V Sukhoverkov; Joel Haywood; Karen J Breese; Mark F Fisher; Keith A Stubbs; Charles S Bond; Joshua S Mylne
Journal:  Plant Commun       Date:  2022-04-09

3.  Bisubstrate inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: Transition state analogs for high affinity binding.

Authors:  Genbin Shi; Gary X Shaw; Fengxia Zhu; Sergey G Tarasov; Xinhua Ji
Journal:  Bioorg Med Chem       Date:  2020-11-09       Impact factor: 3.641

4.  Influence of Sulfonamide Contamination Derived from Veterinary Antibiotics on Plant Growth and Development.

Authors:  Mi Sun Cheong; Kyung Hye Seo; Hadjer Chohra; Young Eun Yoon; Hyeonji Choe; Vimalraj Kantharaj; Yong Bok Lee
Journal:  Antibiotics (Basel)       Date:  2020-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.